BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20843504)

  • 1. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy.
    Ashkenazi-Hoffnung L; Merlob P; Stahl B; Klinger G
    Isr Med Assoc J; 2013 Jan; 15(1):23-6. PubMed ID: 23484234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2015 Mar; 15():59. PubMed ID: 25884778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.
    Costantine MM; Matok I; Chiossi G; Clark S; Miodovnik M; Umans JG; Caritis S; Hankins GD; Koren G
    Ther Drug Monit; 2012 Oct; 34(5):569-73. PubMed ID: 22972538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial.
    Matok I; Umans J; Feghali MN; Clark S; Caritis S; Miodovnik M; Hankins G; Mattison DR; Nordeng H; Koren G
    J Obstet Gynaecol; 2013 Aug; 33(6):557-60. PubMed ID: 23919849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.
    Oliveira LG; Capp SM; You WB; Riffenburgh RH; Carstairs SD
    Obstet Gynecol; 2014 Oct; 124(4):735-742. PubMed ID: 25198265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin).
    Gill SK; Garcia-Bournissen F; Koren G
    Ther Drug Monit; 2011 Feb; 33(1):115-9. PubMed ID: 21079545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
    Pope E; Maltepe C; Koren G
    J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing women with nausea and vomiting of pregnancy. Canadian consensus.
    Can Fam Physician; 2000 Feb; 46():299-301. PubMed ID: 10690484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing.
    Boskovic R; Einarson A; Maltepe C; Wolpin J; Koren G
    J Obstet Gynaecol Can; 2003 Oct; 25(10):830-3. PubMed ID: 14532951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age.
    Nulman I; Koren G
    Can J Clin Pharmacol; 2009; 16(3):e400-6. PubMed ID: 19923636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis.
    Persaud N; Meaney C; El-Emam K; Moineddin R; Thorpe K
    PLoS One; 2018; 13(1):e0189978. PubMed ID: 29342163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).
    Bishai R; Mazzotta P; Atanackovic G; Levichek Z; Pole M; Magee LA; Koren G
    Can J Clin Pharmacol; 2000; 7(3):138-43. PubMed ID: 11044759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans J; Hankins G; Koren G
    J Clin Pharmacol; 2013 Mar; 53(3):334-8. PubMed ID: 23444286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.
    Zhang R; Persaud N
    PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
    Madjunkova S; Maltepe C; Koren G
    Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans JG; Hankins G; Mattison DR; Koren G
    J Clin Pharmacol; 2014 Dec; 54(12):1429-33. PubMed ID: 25052410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.
    Atanackovic G; Navioz Y; Moretti ME; Koren G
    J Clin Pharmacol; 2001 Aug; 41(8):842-5. PubMed ID: 11504271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diclegis for nausea and vomiting of pregnancy.
    Med Lett Drugs Ther; 2013 Aug; 55(1422):61-2. PubMed ID: 23917384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.